PanACEA II is a network of presently 5 European and 11 African institutions who share the common vision of developing ground-breaking strategies in TB drug development. PanACEA II is coordinated from Radboudumc Nijmegen. The partners from the consortium meet at a mimimum once per year face to face and have frequent exchange through teleconferences, emails and intranet. The PanACEA secretariat is located at Radboudumc Nijmegen.